Market Overview - A total of 66 stocks in the A-share market hit the daily limit, with 62 stocks hitting the limit after excluding 4 ST stocks, resulting in an overall limit-hitting rate of 75.86% [1] Top Performers - Industrial Fulian had the highest limit order funding exceeding 300 million yuan, followed by Jixin Technology, Jinyiculture, and Founder Technology with limit orders of 334.7 million, 317.1 million, and 256.1 million respectively [2][4] - Chengbang Co. achieved 6 consecutive limit hits, while Jixin Technology and Xuedilong had 4 consecutive limit hits [3] Sector Highlights PCB Sector - Multiple stocks in the PCB sector hit the limit, including Zhongjing Electronics, Yihua New Materials, and Bomeng Electronics, indicating strong performance in this area [5] - Yihua New Materials reported significant gross margin improvement due to enhanced production capacity and product optimization [6] - Bomeng Electronics specializes in the R&D, production, and sales of high-precision printed circuit boards [7] Innovative Pharmaceuticals - Stocks such as Seli Medical, Shenzhou Cell, and Huahai Pharmaceutical also hit the limit, showcasing growth in the innovative drug sector [8] - Shenzhou Cell has developed a series of monoclonal and bispecific antibodies targeting various diseases [8] - Huahai Pharmaceutical focuses on the R&D of innovative macromolecular drugs through its subsidiary [9] Semiconductor Sector - Stocks like Chengbang Co., Haoshanghao, and Yingfangwei saw limit hits, reflecting the semiconductor industry's growth [10] - Chengbang Co. is focusing on the semiconductor storage industry through its subsidiary [10] - Haoshanghao has been involved in the distribution of domestic electronic components for nearly 20 years, assisting clients with chip selection and application design [10] Institutional Activity - The top net purchases by institutions included Shenzhou Cell, Zhongyi Technology, and Huasheng Lithium Battery, with amounts of 119 million, 31.45 million, and 31.44 million respectively [12][13] - The deep stock connect saw a net purchase of 149 million in Pengding Holdings, while Zhongjing Electronics experienced a net sell of 37.84 million [13]

Market Overview - A-shares experienced a broad rise on July 3, with the ChiNext Index surging nearly 2%, while Hong Kong stocks faced downward pressure, with the Hang Seng Index and Hang Seng Tech Index both dropping over 1% [1] - The Shanghai Composite Index closed up 0.18% at 3461.15 points, the Shenzhen Component Index rose 1.17% to 10534.58 points, and the ChiNext Index increased by 1.9% to 2164.09 points, with total trading volume in the Shanghai and Shenzhen markets reaching 133.36 billion yuan, a decrease of over 70 billion yuan from the previous day [1] Innovation Drug Sector - The innovative drug concept saw a resurgence, with stocks like Guangsheng Tang and Shenzhou Cell hitting the 20% limit up, while companies like Shanghai Yizhong and Hot景 Biotech rose over 10% [3][4] - On July 1, the National Healthcare Security Administration and the National Health Commission released measures to support the high-quality development of innovative drugs, focusing on R&D support, insurance directory, clinical application, multi-payment, and security measures [6] - Citic Securities indicated that the policy reflects the government's commitment to supporting the entire chain of innovative drug development, enhancing market space for innovative drugs [5][6] Computing Power Industry - Stocks in the computing power supply chain, including PCB and composite copper foil, saw collective gains, with Yihua New Materials and Zhongyi Technology both hitting the 20% limit up, and Tongguan Copper Foil rising nearly 14% [8][9] - The domestic demand for computing power continues to improve, with leading companies in optical modules and switches expected to perform well [10] Consumer Electronics Sector - The consumer electronics sector gained momentum, with Lens Technology rising over 11%, and Industrial Fulian hitting the limit up, while Dongshan Precision increased by over 9% [12][13] - Reports suggest that the recent U.S. tariffs on Vietnamese imports may lead to some orders returning to China, benefiting Chinese OEMs with established supply chains [14]

Market Overview - The A-share market experienced a significant rebound on July 3, with the ChiNext index leading the gains. The Shanghai Composite Index rose by 0.18%, the Shenzhen Component Index increased by 1.17%, and the ChiNext index surged by 1.9% [2] - A total of 3,271 stocks in the two markets rose, with 66 stocks hitting the daily limit up, while 1,866 stocks declined [3] Sector Performance - The computing hardware sector saw a notable increase, with PCB and related stocks leading the charge. Companies such as Zhongjing Electronics, Bomin Electronics, and Jin'an Guoji hit the daily limit up [4] - The innovative drug concept stocks continued their strong performance, with companies like Weiming Pharmaceutical and Shenzhou Cell also hitting the daily limit up [6] Notable Stock Movements - In the computing hardware sector, several stocks showed significant gains, including: - Yimeng New Materials (20.00% increase, current price 32.64) - Zhongyi Technology (19.99% increase, current price 23.89) - Tongguan Copper Foil (13.67% increase, current price 13.80) [5] - In the innovative drug sector, notable performers included: - Guangshengtang (20.00% increase, current price 42.78) - Shenzhou Cell (19.99% increase, current price 73.34) - Shanghai Yizhong (10.82% increase, current price 55.22) [7] Battery Sector - The solid-state battery sector saw a surge in the afternoon, with companies like Dazhongnan, Hongtian Co., and Zhongyi Technology hitting the daily limit up [8] Semiconductor Industry - The U.S. government has lifted export licensing requirements for chip design software sales to China, a move that is part of a broader trade agreement aimed at easing restrictions on key technologies [11] - Major EDA (Electronic Design Automation) companies, including Synopsys, Cadence Design Systems, and Siemens, have been notified that they no longer need government approval to operate in China, which is expected to enhance their business prospects in the region [12][13] - The EDA market, valued at $11.5 billion, is dominated by these three companies, which collectively hold a 74% market share [13] - Following the announcement, stocks of Synopsys and Cadence saw significant gains in after-hours trading [15]

Market Overview - A-shares experienced a collective rise with the Shanghai Composite Index up by 0.18%, Shenzhen Component Index up by 1.17%, and ChiNext Index up by 1.90% as of the market close on July 3 [1][2]. Sector Performance - Strong performance was noted in sectors such as recombinant proteins, innovative pharmaceuticals, PCB, and solid-state batteries, while coal, deep-sea technology, nuclear power, and photolithography sectors saw adjustments [4]. - The solid-state battery sector saw significant gains, with companies like Dazhongnan, Hongtian Co., and Zhongyi Technology hitting the daily limit [5]. - PCB concept stocks collectively surged, with eight stocks including Zhongjing Electronics, Bomin Electronics, and Jin'an Guoji reaching the daily limit [6]. Individual Stock Highlights - Notable stock performances included: - Yihau New Materials (+20.00% to 32.64) - Zhongyi Technology (+19.99% to 23.89) - Tongguan Copper Foil (+13.67% to 13.80) - Bomin Electronics (+10.04% to 10.41) - Fangzheng Technology (+10.04% to 5.59) - Jin'an Guoji (+10.03% to 10.31) - Zhongjing Electronics (+10.01% to 15.60) [7]. Capital Flow - Main capital inflows were observed in the electronics, pharmaceutical biology, and communication sectors, while outflows were noted in non-ferrous metals, basic chemicals, and banking sectors [8]. - Specific stock inflows included: - Industrial Fulian with a net inflow of 1.773 billion - Ningde Times with 1.319 billion - Luxshare Precision with 745 million [9]. - Notable outflows included: - Yuyin Co. with a net outflow of 748 million - Shanzigao Technology with 457 million - Yaxing Anchor Chain with 386 million [10]. Institutional Insights - Galaxy Securities indicated that the market is consolidating around the 5-day moving average, suggesting patience in waiting for variables [12]. - CITIC Construction noted that the market is maintaining a volatile state with signs of high-low switching amid thematic rotations [13]. - Everbright Securities mentioned that the market is using time to digest divergences above the 3400 level [14].

Group 1 - The ChiNext index showed strong performance, rising over 1% with active participation from innovative drug and commercial aerospace concepts [1][2][3] - The ChiNext index rose by 1.36% at midday, with notable stocks such as Lens Technology (300433) increasing over 8% and Ningde Times (300750) nearly 4% [2][3] - The innovative drug concept saw significant gains, with multiple stocks hitting the daily limit, including ShenZhou Cell and Jiuzhitang [3][6] Group 2 - The Hong Kong stock market experienced a slight decline, with the Hang Seng Index dropping over 1% at one point [9] - Multi-point Intelligence saw its stock price surge, with an intraday increase nearing 90%, attributed to its plans for a stablecoin license [10][12] - The pharmaceutical sector in the Hong Kong market rose over 2%, with several stocks, including Huahao Zhongtian Pharmaceutical-B, increasing over 10% [12] Group 3 - JiXin Technology (601218) experienced its fourth consecutive trading day of hitting the daily limit, while issuing a risk warning regarding its high rolling P/E ratio of 72.85 compared to the industry average of 22.24 [7][8] - SaiLi Medical also hit the daily limit for the third consecutive day, with the company confirming no undisclosed significant information affecting its stock price [8]

Core Viewpoint - The A-share market experienced slight fluctuations with the ChiNext index rising over 1%, driven by active performance in innovative pharmaceuticals and commercial aerospace concepts [1][3][10]. Market Performance - The A-share market showed a narrow range of fluctuations, with the Shanghai Composite Index up 0.07%, Shenzhen Component Index up 0.75%, and ChiNext Index up 1.36% [3][4]. - The Hong Kong stock market saw a slight decline, with significant volatility in individual stocks, notably Multi-Point Intelligence, which surged nearly 90% during trading [2][16]. Sector Performance - Key sectors showing gains included communication equipment, components, and public transportation, while sectors like shipping, coal, and mineral products faced declines [5]. - The innovative pharmaceutical sector saw substantial increases, with several stocks hitting the daily limit, including ShenZhou Cell and Jiuzhitang [6][19]. Notable Stocks - In the ChiNext index, notable performers included Lens Technology, which rose over 8%, and other companies like Huayi Group and Ningde Times, which saw increases of nearly 4% [4]. - JiXin Technology experienced its fourth consecutive trading day of hitting the daily limit, prompting a risk warning due to its high rolling P/E ratio of 72.85 compared to the industry average of 22.24 [11][12]. Company Announcements - Companies like Seer Medical and JiXin Technology issued announcements regarding stock trading risks and performance warnings, highlighting significant declines in net profits and high pledge ratios of major shareholders [12][14]. - Multi-Point Intelligence confirmed its plans to apply for a stablecoin license, indicating a strategic focus on the cryptocurrency sector to enhance cross-border payment efficiency [18].

金十数据7月3日讯，A股三大指数早盘集体上涨，截至午间收盘，上证综指涨0.07%，深证成指涨 0.75%，创业板指涨1.36%。全市场半日成交额8063亿元，较上日缩量611亿元。全市场超2500只个股上 涨。板块个股方面，创新药概念股延续昨日涨势，神州细胞、塞力医疗、未名医药涨停。消费电子板块 活跃，新亚电子、朝阳科技涨停。军工股震荡走低，中船应急跌超10%；游戏股表现低迷，星辉娱乐跌 超6%，迅游科技、富春股份跌超3%。 A股午评：三大股指早盘集体收涨 创新药概念股延续强势 ...

Report Summary 1) Report Industry Investment Rating No information provided. 2) Core View of the Report The stock index futures are expected to maintain a volatile pattern [1]. 3) Summary by Relevant Catalogs a) Stock Index Futures Data Tracking - On July 2, the closing prices of the four major stock index futures contracts showed mixed trends. IF rose 0.15%, IH rose 0.17%, IC fell 0.26%, and IM fell 0.39% [1]. - On the trading day, the total trading volume of stock index futures declined, indicating a cooling of investors' trading enthusiasm. Specifically, the total trading volume of IF increased by 803 lots, IH increased by 5,144 lots, IC decreased by 3,207 lots, and IM decreased by 16,123 lots. In terms of positions, the total positions of IF increased by 676 lots, IH decreased by 656 lots, IC decreased by 1,936 lots, and IM decreased by 8,772 lots [1][2]. b) Basis of Stock Index Futures Graphs of the basis of IF, IH, IC, and IM from June 6 to July 2 were presented [4]. c) Changes in Positions of the Top 20 Members in Stock Index Futures - For IF contracts, the changes in long and short positions of different contracts varied. For example, in IF2507, long positions increased by 393 lots and short positions decreased by 585 lots [5]. - For IH contracts, the changes in long and short positions also differed among contracts. For instance, in IH2507, long positions increased by 57 lots and short positions increased by 513 lots [5]. - For IC contracts, in IC2509, long positions decreased by 1,411 lots and short positions decreased by 1,014 lots [5]. - For IM contracts, in IM2507, long positions decreased by 2,240 lots and short positions decreased by 2,144 lots [5]. d) Trend Intensity and Important Drivers - The trend intensity of IF and IH is 1, and that of IC and IM is also 1. The trend intensity ranges from -2 to 2, with -2 being the most bearish and 2 being the most bullish [6]. - Important drivers include statements from the Minister of Finance and the member of the Monetary Policy Committee of the People's Bank of China, as well as the performance of the stock market, such as the differentiation of Shanghai and Shenzhen stock indices, and the performance of various concept stocks [6].

点击蓝字，关注我们 今日上午港股 1.博彩股集体高开， 新濠国际发展(00200)涨9.65%，银河娱乐(00027)涨9.04%，金沙中国(01928)涨6%； 永利澳门(01128)涨5.17%；美高梅中国(02282)涨4.97%。 2.六福集团(00590)再涨超4%， 中银国际表示，六福在2025财年下半年的营运表现超出预期。除了金价 上涨外，选择成毅作为新品牌代言人以及推出具有中国风设计的新产品系列也助力提升销售势头。 3.太古地产(01972)涨超3% ， 消息面上，近日，太古地产及太古公司联合公布，各方于本公告日期就出 售权益(即零售权益、停车场资产及设施权益)的买卖订立交易文件。 4.首程控股(00697)涨超3%， 消息面上，首程控股发布公告，近日，集团在北京成功举办了主题为"首程 领航，智创未来"的机器人产业生态峰会暨投资人大会。 5.内银股早盘普涨， 民生银行(01988)涨3.82%；中信银行(00998)涨3.21%；建设银行(00939)涨2.53%；工 商银行(01398)涨1.93%。 12.电力股早盘回暖， 大唐发电(00991)涨4.55%；华能国际(00902)涨4.0 ...

Market Overview - A-shares experienced a strong opening on July 1, with the Shanghai Composite Index rising significantly, driven by the banking and power sectors, and total market turnover around 1.5 trillion yuan [1] - The banking sector showed a robust rebound, with all stocks in the sector rising, and Shanghai Pudong Development Bank reaching a historical high with a market capitalization of 432.18 billion yuan [2] Banking Sector Performance - The banking sector index increased by approximately 20% year-to-date, with a cumulative rise of nearly 70% since the end of 2023 [2] - Notable individual stock performances included Suzhou Bank rising over 5%, Xiamen Bank nearly 4%, and Hangzhou Bank over 3% [2] - The overall banking sector closed up 1.84% on July 1, ranking fifth among industry sectors for the day [2] Innovative Drug Sector - The innovative drug sector saw significant gains, with a total increase of 3.01% by the end of the trading day, ranking third among industry sectors [4] - Key stocks in this sector included Frontline Bio, which hit the daily limit, and several others like Guizhou Bailing and Seer Medical also reaching their daily limits [4] - The sector has been active since mid-May, with a notable surge in trading volume and stock prices [4] Policy Support for Innovative Drugs - The National Healthcare Security Administration and the National Health Commission issued measures to support the high-quality development of innovative drugs, focusing on R&D, market access, and payment systems [5] - These measures aim to address key issues in the innovative drug sector and promote genuine innovation [5] International Transactions in Innovative Drugs - There has been a surge in international transactions for innovative drugs, with a total of $45.5 billion in authorized transactions by Chinese companies from January to May 2025, surpassing the total for the first half of 2024 [6] - The year 2025 is expected to be significant for domestic innovative drug companies as they transition from generic to innovative drugs, with some companies reaching breakeven and profitability [6]